Show simple item record

dc.contributor.authorGrinde, Maria Tunset
dc.contributor.authorHilmarsdòttir, Bylgja
dc.contributor.authorTunset, Hanna Maja
dc.contributor.authorHenriksen, Ida Marie
dc.contributor.authorKim, Jana
dc.contributor.authorHaugen, Mads Haugland
dc.contributor.authorRye, Morten Beck
dc.contributor.authorMælandsmo, Gunhild Mari
dc.contributor.authorMoestue, Siver Andreas
dc.date.accessioned2019-08-29T06:27:30Z
dc.date.available2019-08-29T06:27:30Z
dc.date.created2019-04-23T10:01:02Z
dc.date.issued2019
dc.identifier.citationGrinde, M. T., Hilmarsdòttir, B., Tunset, H. M., Henriksen, I. M., Kim, J., Haugen, M. H., Rye, M. B., Mælandsmo, G. M. & Moestue, S. A. (2019). Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer. Breast Cancer Research, 21: 61. doi:nb_NO
dc.identifier.issn1465-542X
dc.identifier.urihttp://hdl.handle.net/11250/2611489
dc.language.isoengnb_NO
dc.publisherBMCnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleGlutamine to proline conversion is associated with response to glutaminase inhibition in breast cancernb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.rights.holder© 2019 The Author(s)nb_NO
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gynekologi og obstetrikk: 756nb_NO
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762nb_NO
dc.source.pagenumber13nb_NO
dc.source.volume21nb_NO
dc.source.journalBreast Cancer Researchnb_NO
dc.identifier.doi10.1186/s13058-019-1141-0
dc.identifier.cristin1693367
dc.relation.projectKreftforeningen: 90393200nb_NO
dc.relation.projectNorges forskningsråd: 239940nb_NO


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal